Genomic landscape and efficacy of HER2-targeted therapy in patients with HER2-mutant non-small cell lung cancer

Overview of attention for article published in Frontiers in oncology, April 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 25,710 followers.

Genomic landscape and efficacy of HER2-targeted therapy in patients with HER2-mutant non-small cell lung cancer https://t.co/WrfaV56rbH https://t.co/0x2KRcuLOF

20 Apr 2023

Reply Repost Favourite

Genomic landscape and efficacy of HER2-targeted therapy in patients with HER2-mutant non-small cell lung cancer https://t.co/xm6fzKVcz7 https://t.co/MyBaO8iiP6

14 Apr 2023

Reply Repost Favourite

RT @FrontOncology: New research: Genomic landscape and efficacy of HER2-targeted therapy in patients with HER2-mutant non-small cell lung c…

14 Apr 2023

Reply Repost Favourite

New research: Genomic landscape and efficacy of HER2-targeted therapy in patients with HER2-mutant non-small cell lung cancer: Background HER2-targeted therapy provides survival benefits to HER2-mutant non-small cell lung cancer (NSCLC). A… https://t.co/p

13 Apr 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.